Abbott to Discontinue ProSom (estazolam)

Abbott, Illinois -- Abbott will discontinue ProSom (estazolam). Abbott took this action for commercial reasons, availability of generic estazolam and available alternate therapies. To view the letter to health care providers, please visit: http://www.fda.gov/cder/drug/shortages/prosom_dhcp.pdf

MORE ON THIS TOPIC